Latest Breaking News On - Celularity inc - Page 1 : comparemela.com

Harnessing natural killer cells to combat age-related diseases

How do senescent cells contribute to degenerative diseases, cancer, and immuno-senescence? Senescence is a central hallmark of aging. Telomere damage, epigenetic dysregulation, DNA damage and.

Bob haririRobert haririCelgene corporationAnthrogenesis corporationHuman longevity incRussell publishingCelularity incAllogeneic placental pluripotent cellsCelgene cellularRussell publishing limited

Celularity (CELU) Receives Nasdaq Notice Regarding Late 10-Q Filing

Celularity (CELU) Receives Nasdaq Notice Regarding Late 10-Q Filing
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Celularity incExchange commissionListing qualifications departmentNasdaq stock marketListing qualificationsAnnual reportNasdaq capital market

Celularity Inc Announces Receipt of Nasdaq Notice

Celularity Inc Announces Receipt of Nasdaq Notice
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Ali nagy michaela fawcettCarlos ramirezExchange commissionStrategic communicationsNasdaq stock marketCelularity incListing qualifications departmentUs securities exchangeListing qualificationsAnnual reportNasdaq capital marketSecurities litigation reform actExchange actVice president

Celularity Inc Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

Celularity Inc Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Ali nagy michaela fawcettCarlos ramirezCelularity incExchange commissionUs securities exchangeStrategic communicationsListing qualifications departmentNasdaq stock marketAnnounces receiptNasdaq notice regarding late formListing qualificationsAnnual reportNasdaq capital marketSecurities litigation reform actExchange actVice president

Celularity Inc (NASDAQ:CELU) Short Interest Up 51 4% in April

Celularity Inc. (NASDAQ:CELU – Get Free Report) was the recipient of a large increase in short interest during the month of April. As of April 30th, there was short interest totalling 595,000 shares, an increase of 51.4% from the April 15th total of 393,100 shares. Approximately 5.6% of the shares of the company are short […]

Celularity incInvestment advisorsSecurities exchange commissionGet free reportFree reportCell therapyDegenerative diseaseCelularity daily